All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-MLANA DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-2265-FY | CBFYM-0113 | Mouse | Human | Recombinant fragment of human MLANA (AA: 48-118) expressed in E. Coli | ||
DMAb-2266-FY | CBFYM-0235 | Mouse | Human | IgG1, IgG2b | ||
DMAb-2267-FY | CBFYM-0266 | Mouse | Human | IgG1, IgG2a, IgG2b | ||
DMAb-2268-FY | CBFYM-0343 | Mouse | Human | IgG1, IgG2a, IgG2b | Recombinant tyrosinase protein (T311) and extract of pigmented melanoma metastases from lymph nodes (HMB45) | |
DMAb-2269-FY | CBFYM-0363 | Rabbit | Human | IgG | Recombinant full length human MART-1 | |
DMAb-2270-FY | CBFYM-0364 | Mouse | Human | IgG1, k | This antibody recognizes a protein doublet of 20-22kDa, identified as MART-1 | |
DMAb-2271-FY | CBFYM-0427 | Mouse | Human | IgG2b | ||
DMAb-2272-FY | CBFYM-0431 | Mouse | Human | IgG2b | ||
DMAb-2273-FY | CBFYM-0432 | Mouse | Human | IgG1 | ||
DMAb-2274-FY | CBFYM-0653 | Mouse | Human | IgG1 | ||
DMAb-2275-FY | CBFYM-0654 | Mouse | Human | IgG2b, k | ||
DMAb-2276-FY | CBFYM-2270 | Mouse | Human | IgG1 | Recombinant protein corresponding to human MART-1. Cellular Localization: Cytoplasmic | |
DMAb-2277-FY | CBFYM-2271 | Mouse | Human | Recombinant hMART-1 protein (A103; M2-7C10; M2-9E3). Cellular Localization: Cytoplasmic | ||
DMAb-2278-FY | CBFYM-2272 | Mouse | Human | IgG2b, k | Recombinant hMART-1 protein | |
DMAb-2279-FY | CBFYM-2273 | Mouse | Human | IgG1 | Full length human recombinant protein of human MLANA (NP_005502) produced in HEK293T cell | |
DMAb-2280-FY | CBFYM-2274 | Mouse | Human | IgG1 | Human recombinant protein fragment corresponding to amino acids 48-118 of human MLANA (NP_005502) produced in E. coli | |
DMAb-2281-FY | CBFYM-2275 | Mouse | Human | IgG2b | Full length human recombinant protein of human MLANA(NP_005502) produced in HEK293T cell | |
DMAb-2282-FY | CBFYM-2276 | Mouse | Human | IgG1 | KLH conjugated synthetic peptide between 60-92 AA from the C-terminal region of human MART-1/Melan-A | |
DMAb-2283-FY | CBFYM-2277 | Mouse | Human | IgG2b, k | Recombinant hMART-1 protein. MW: 18kD. Cellular Localization: Cytoplasmic | |
DMAb-2284-FY | CBFYM-2278 | Mouse | Human | IgG1 | Recombinant MART-1 protein. Cellular Localization: Cytoplasmic | |
DMAb-2285-FY | CBFYM-2279 | Rabbit | Human | IgG | Synthetic peptide corresponding to a C-terminal sequence of human MART-1 (melanoma antigen recognized by T cells 1) | |
DMAb-2286-FY | CBFYM-2280 | Mouse | Human | IgG2a | Recombinant human Melan-A/MART-1, Asn52-Pro118 | |
DMAb-2287-FY | CBFYM-2281 | Rabbit | Human | IgG | Recombinant human protein was used for this MART-1 antibody |
There are currently no customer reviews or questions for Anti-MLANA DNA-encoded mAb (DMAb), pVAX1 (DMAb-2265-FY). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION